CoChat

A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer’s disease

Open access
Oh, Hamilton Se-Hwee, Urey, Deniz Yagmur, Karlsson, Linda, Zhu, Zeyu, Shen, Yuanyuan, Farinas, Amelia, Timsina, Jigyasha, Duggan, Michael R., Chen, Jingsha, Guldner, Ian H., Morshed, Nader, Yang, Chengran, Western, Daniel, Ali, Muhammad, Le Guen, Yann, Trelle, Alexandra, Herukka, Sanna-Kaisa, Rauramaa, Tuomas, Hiltunen, Mikko, Lipponen, Anssi, Luikku, Antti J., Poston, Kathleen L., Mormino, Elizabeth, Wagner, Anthony D., Wilson, Edward N., Channappa, Divya, Leinonen, Ville, Stevens, Beth, Ehrenberg, Alexander J., Gottesman, Rebecca F., Coresh, Josef, Walker, Keenan A., Zetterberg, Henrik, Bennett, David A., Franzmeier, Nicolai, Hansson, Oskar, Cruchaga, Carlos, Wyss-Coray, Tony · 2025 · Nature Medicine
Cited by 121

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

Rates of cognitive decline in Alzheimer’s disease (AD) are extremely heterogeneous, with ages of symptom onset ranging from age 40-100 years and conversion from mild cognitive impairment to AD dementia taking 2-20 years. Development of biomarkers for amyloid-beta (Aβ) and tau protein aggregates, the hallmark pathologies of AD, have improved patient monitoring/stratification and drug development, but they still only explain 20-40% of the variance in cognitive impairment (CI) in AD. To discover additional molecular drivers and biomarkers of AD dementia, we perform cerebrospinal fluid (CSF) proteomics on 3,416 individuals from six deeply phenotyped prospective AD case-control cohorts. We identify synapse proteins as the strongest correlates of CI, independent of Aβ and tau. Using machine learning we derive the CSF YWHAG:NPTX2 synapse protein ratio, a robust correlate of CI, which explains 27% of the variance in CI beyond CSF PTau181:Aβ42, 10% beyond tau PET, and 50% beyond CSF NfL in Aβ positive individuals. We find YWHAG:NPTX2 also increases with normal aging as early as age 20 and increases at a faster rate in APOE4 carriers and autosomal dominant-AD mutation carriers. Most notably, YWHAG:NPTX2+ individuals (top 25 th percentile) are 15-times (HR=15.4 [10.6-22.2]) more likely to experience cognitive decline over 15 years compared to YWHAG:NPTX2– individuals (bottom 25 th percentile), and this rises to 19-times (HR=18.9 [10.83-32.9]) with additional stratification by Aβ and phosphorylated tau status. Lastly, we perform plasma proteomics on 4,245 individuals to develop a plasma-based signature of CI which partly recapitulates CSF YWHAG:NPTX2. Overall, our findings underscore CSF YWHAG:NPTX2 and the corresponding plasma signature as robust prognostic biomarkers for AD onset and progression beyond gold-standard biomarkers of Aβ, tau, and neurodegeneration and implicate synapse dysfunction as a core driver of AD dementia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-025-03565-2

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Cited by

See all 121

Metadata

Authors
Oh, H. S.-H., Urey, D. Y., Karlsson, L., Zhu, Z., Shen, Y., Farinas, A., Timsina, J., Duggan, M. R., Chen, J., Guldner, I. H., Morshed, N., Yang, C., Western, D., Ali, M., Le Guen, Y., Trelle, A., Herukka, S.-K., Rauramaa, T., Hiltunen, M., Lipponen, A., Luikku, A. J., Poston, K. L., Mormino, E., Wagner, A. D., Wilson, E. N., Channappa, D., Leinonen, V., Stevens, B., Ehrenberg, A. J., Gottesman, R. F., Coresh, J., Walker, K. A., Zetterberg, H., Bennett, D. A., Franzmeier, N., Hansson, O., Cruchaga, C., & Wyss-Coray, T.
Venue
Nature Medicine
Published
2025-03-31
Volume
31
Issue
5
Pages
1592-1603
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W4409087059
Cited by
121
References
41
FWCI
74.71
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer’s disease. https://app.cochat.ai/papers/10.1038/s41591-025-03565-2
The paper
Oh, H. S.-H., Urey, D. Y., Karlsson, L., Zhu, Z., Shen, Y., Farinas, A., Timsina, J., Duggan, M. R., Chen, J., Guldner, I. H., Morshed, N., Yang, C., Western, D., Ali, M., Le Guen, Y., Trelle, A., Herukka, S.-K., Rauramaa, T., Hiltunen, M., . . . Wyss-Coray, T. (2025). A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer’s disease. Nature Medicine. https://doi.org/10.1038/s41591-025-03565-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.